Domestic makers struggling to cope with sluggish OTC sales via price increase

Local pharmaceutical manufacturers are poised to increase the prices of their flagship products in a bid to achieve their sales target this year, as rising global prices of crops, oil and other raw materials are weighing on the Korean economy, for which the 6 percent growth target seems difficult to achieve.

Some drug makers, such as Myungmoon Pharm and Boehringer Ingelheim Korea, are lookin...